Literature DB >> 1467772

The rising trend in oesophageal adenocarcinoma and gastric cardia.

J Powell1, C C McConkey.   

Abstract

The incidence of cancer of the oesophagus and stomach in the West Midlands region of England have been analysed for the 25 years 1962-86. Overall, cancer of the oesophagus is increasing (from 3.45 per 100,000 in 1962-66 to 4.37 in 1982-86) and stomach cancer is decreasing (19.22 and 16.54 respectively). However, when analysed by histological type and subsite the picture is very different. In oesophagus, squamous cell carcinoma shows only a slight increase whereas for adenocarcinoma the increase is highly significant (from 0.14 to 0.76). In stomach, cardia shows a very similar pattern to adenocarcinoma of oesophagus (increasing from 0.75 to 2.96) but pyloric antrum is decreasing (from 2.63 to 2.32). The rapid changes in investigative procedures over the period have resulted in increasing numbers with histological confirmation and subsite specification but despite these confounding factors, comparative analyses still indicate a real increase in adenocarcinoma of oesophagus and cardia. Although the incidence of both are greater in men than in women, the proportional rates of increase, particularly for cardia, are very similar in both sexes, indicating a common aetiological factor or factors. Analysis by social-economic group reveals that the increases observed are not uniform throughout the population but are relatively higher in professional classes (1 and 2).

Entities:  

Mesh:

Year:  1992        PMID: 1467772     DOI: 10.1097/00008469-199204000-00008

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  43 in total

Review 1.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Authors:  J A Jankowski; N A Wright; S J Meltzer; G Triadafilopoulos; K Geboes; A G Casson; D Kerr; L S Young
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

2.  Gastro-oesophageal cancer: death at the junction.

Authors:  J A Jankowski; I Perry; R F Harrison
Journal:  BMJ       Date:  2000 Aug 19-26

3.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

4.  Protagonist: endoscopic surveillance of patients with Barrett's oesophagus.

Authors:  H Barr
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 5.  Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies.

Authors:  Shinichi Hasegawa; Takaki Yoshikawa
Journal:  Gastric Cancer       Date:  2010-07-03       Impact factor: 7.370

Review 6.  Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?

Authors:  J Lagergren
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

7.  Oesophageal cancer in Britain.

Authors:  J Powell; W H Allum
Journal:  BMJ       Date:  1992-05-23

8.  Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study.

Authors:  Hani Tamim; André Duranceau; Long-Qi Chen; Jacques Lelorier
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 9.  Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs.

Authors:  J Dent; D Armstrong; B Delaney; P Moayyedi; N J Talley; N Vakil
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

10.  The association between cagA+ H. pylori infection and distal gastric cancer: a proposed model.

Authors:  Mohammed S Al-Marhoon; Sheila Nunn; Roger W Soames
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.